This suggests that TRPC5 could be an immunohistochemistry marker to distinguish SCC from BCC and could partially explain the low likelihood of spread in BCC as compared to SCC/MM along with other data from our previous reports on pH-sensitive receptors in these entities. The gene discussed is TRPC5; the disease is Miyoshi myopathy.